Stream Neuroscience co-founder & CEO interviewed on NPR WHYY, “The Pulse” on snit-seizure drug discovery.
At the University of Calgary, scientists say this tiny, tropical fish may be a quicker, cheaper way to find new drugs to treat epilepsy.
Cumming researchers develop new method to discover drugs to treat epilepsy
University of Calgary news release — 19 April 2018
New method to discover drugs to treat epilepsy
ScienceDaily, April 21, 2018
A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.
Ibhazehiebo K, Gavrilovici C, de la Hoz CL, Ma SC, Rehak R, Kaushik G, Meza Santoscoy PL, Scott L, Nath N, Kim DY, Rho JM, Kurrasch DM — 24 January 2018
A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target
Ibhazehiebo, K, et al., Brain, 2018 Mar
Best Publication Award, Canadian League Against Epilepsy
Awarded to Kingsley Ibhazehiebo for the Brain 2018 paper— January 2018
Stream Neuroscience co-founder & CEO discusses “how model organisms inform human health” on a nationally syndicated CBC piece.
Publication is no longer available online
Discovery of triazines as selective PDE4B versus PDE4D inhibitors
Dogra, D., Epilepsia 2018 Mar
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
Burgin, AB, et al., Nat Biotechnol. 2010 Jan